KRAS and pancreatic neoplasm: In summary, this study demonstrates that RAGE expression is regulated by a NF-κB-dependent pathway and the upregulated binding of RAGE to mutant KRAS facilitates HIF1α activation in a range of pancreatic tumor cells, as well as a spontaneous pancreatic tumor model in transgenic mice (Figure 6).